Guangdong Guangrun Group

Guangdong Guangrun Group is a privately held Chinese investment and industrial holding company with activities spanning pharmaceutical R&D, manufacturing, sales, health products, medical-related businesses, and investment. The group appears to function primarily as a parent and controlling shareholder rather than as a standalone drug developer. Public disclosures indicate it is the controlling shareholder of Yipinhong Pharmaceutical Group and has also invested through affiliated vehicles such as Montesy Investment and Guangrun Health Industry (Hong Kong). Available evidence suggests its healthcare relevance comes mainly from ownership, investment, and group-level management of pharmaceutical and health-related assets rather than from an independently disclosed clinical pipeline. As a result, it is best characterized as a diversified healthcare-oriented holding and investment group rather than a pure-play biotech company.